Generic Name and Formulations:
Bethanechol chloride 5mg, 10mg, 25mg, 50mg; scored tabs.
Indications for URECHOLINE:
Post-op and post-partum nonobstructive urinary retention and retentive neurogenic urinary atony.
Take on empty stomach. Initially 5–10mg every hour until effective or max 50mg, then 10–50mg 3–4 times daily.
Hyperthyroidism. Peptic ulcer. Asthma. Bradycardia. Hypotension. Vasomotor instability. Coronary artery disease. Epilepsy. Parkinsonism. Obstructive uropathies. Questionable GI or bladder integrity. Obstructive, spastic, inflammatory GI disorders. Vagotonia. Peritonitis. When increased GI or bladder muscle activity may be harmful.
Reflux urinary infection. Pregnancy (Cat.C). Nursing mothers: not recommended.
Severe abdominal symptoms and hypotension with ganglionic blockers.
Cholinergic effects, GI upset, asthma, headache, facial flushing, malaise, orthostatic hypotension.
Endocrinology Advisor Articles
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Dulaglutide Effective for Patients With T2D, Moderate to Severe CKD
- Incidence of Diabetes Influenced by Endocrine-Disrupting Chemicals in the Environment
- Guidelines for Management of Hypothalamic-Pituitary, Growth Disorders in Childhood Cancer Survivors
- Romosozumab: Effective in Men With Osteoporosis
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- NT-proBNP May Predict Cardiovascular Outcomes in Type 2 Diabetes
- Placebo Effect of Various Female Sexual Dysfunction Drug Txs Assessed
- Link Between Oral Diabetes Medications and Bullous Pemphigoid
- Calcium Channel Blocker May Benefit Patients With Type 1 Diabetes
- β-Cell Function in Youth With Impaired Glucose Tolerance, T2D